FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

José Gómez-Puerta

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Pregnancy

Co-author Network

Publications

TOP 3
Raimon Sanmartí; Octavi Viñas; Sonia Cabrera-Villalba; José A Gómez-Puerta; Ma Victoria Hernández; Julio Ramirez; Virginia Ruiz-Esquide; Georgina Salvador; Juan D Cañete
Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study.
José A Gómez-Puerta; Luis F Quintana; Manuel Ramos-Casals; John H Stone; Xavier Bosch
B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
Virginia Ruiz-Esquide; Ivonne Vazquez; Octavi Viñas; Juan D Cañete; M Guadalupe Ercilla; Antonio Gómez-Centeno; José A Gómez-Puerta; Eduard Graell; Isabel Haro; Raimon Sanmartí
Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of José Gómez-Puerta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Raimon Sanmartí; Octavi Viñas; Sonia Cabrera-Villalba; José A Gómez-Puerta; Ma Victoria Hernández; Julio Ramirez; Virginia Ruiz-Esquide; Georgina Salvador; Juan D Cañete
Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study.
The Journal of rheumatology 2012;39(10):1929-33.
2012: José A Gómez-Puerta; Luis F Quintana; Manuel Ramos-Casals; John H Stone; Xavier Bosch
B-cell depleting agents for ANCA vasculitides: a new therapeutic approach.
Autoimmunity reviews 2012;11(9):646-52.
2011: Virginia Ruiz-Esquide; Ivonne Vazquez; Octavi Viñas; Juan D Cañete; M Guadalupe Ercilla; Antonio Gómez-Centeno; José A Gómez-Puerta; Eduard Graell; Isabel Haro; Raimon Sanmartí
Effects of smoking on disease activity and radiographic progression in early rheumatoid arthritis.
The Journal of rheumatology 2011;38(12):2536-9.
2011: Morteza Malakoutikhah; Raimon Sanmartí; María J Gómara; José A Gómez-Puerta; Isabel Haro
The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis.
Journal of medicinal chemistry 2011;54(21):7486-92.
2011: Isabel Haro; María J Gómara; María L Pérez; Odette Viñas; Guadalupe Ercilla; José A Gómez-Puerta; Raimon Sanmartí
Antibodies against β-fibrin synthetic peptides: a study of their association with the immunogenetic background and disease course of rheumatoid arthritis patients.
European journal of medicinal chemistry 2011;46(4):1095-102.
2011: Laia Gifre; Virginia Ruiz-Esquide; Antoni Xaubet; José A Gómez-Puerta; M Victoria Hernández; Raimon Sanmartí
Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
Archivos de bronconeumología 2011;47(4):208-12.
2011: Raimon Sanmartí; José A Gómez-Puerta
[Biomarkers in rheumatoid arthritis].
Reumatología clinica 2011;6S3():S25-8.
2011: José A Gómez-Puerta; Xavier Bosch
Therapy: Spleen tyrosine kinase inhibitors--novel therapies for RA?
Nature reviews. Rheumatology 2011;7(3):134-6.
2011: Pablo Engel; José A Gómez-Puerta; Manuel Ramos-Casals; Francisco Lozano; Xavier Bosch
Therapeutic targeting of B cells for rheumatic autoimmune diseases.
Pharmacological reviews 2011;63(1):127-56.
2010: José A Gómez-Puerta; Emma García-Melchor
[Young woman with relapsing arthritis].
Reumatología clinica 2010;6(1):58-62.
2009: José A Gómez-Puerta; Xavier Bosch
Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update.
The American journal of pathology 2009;175(5):1790-8.
2009: Concepción Moll; Mónica Bogas; José A Gómez-Puerta; Raquel Celis; Ivonne Vázquez; Fernando Rodríguez; Eduardo Kanterewicz; Raimon Sanmarti; Juan D Cañete
Macroscopic features of knee synovitis in early untreated Behçet disease and psoriatic arthritis.
Clinical rheumatology 2009;28(9):1053-7.
2009: José A Gómez-Puerta; J Sanin-Blair; Claudio Galarza-Maldonado
Pregnancy and catastrophic antiphospholipid syndrome.
Clinical reviews in allergy & immunology 2009;36(2-3):85-90.
2009: Ricard Cervera; Silvia Bucciarelli; Miguel A Plasín; José A Gómez-Puerta; Joan Plaza; Guillermo Pons-Estel; Yehuda Shoenfeld; Miguel Ingelmo; Gerard Espinos
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
Journal of autoimmunity 2009;32(3-4):240-5.
2009: Delia Taverner; José A Gómez-Puerta
[Dyspnea in a patient with systemic lupus erythematosus].
Reumatología clinica 2009;5(2):88-91.
2009: E Graell; I Vazquez; Marta Larrosa; José Ramón Rodríguez-Cros; Ma Victoria Hernández; Jordi Gratacós; A Gómez; Juan D Cañete; José A Gómez-Puerta; Raimon Sanmartí
Disability measured by the modified health assessment questionnaire in early rheumatoid arthritis: prognostic factors after two years of follow-up.
Clinical and experimental rheumatology 2009;27(2):284-91.
2009: José A Gómez-Puerta; Gerard Espinosa; R Morlà; Maria C Cid; Ricard Cervera
Interstitial lung disease as a presenting manifestation of microscopic polyangiitis successfully treated with mycophenolate mofetil.
Clinical and experimental rheumatology 2009;27(1):166-7.
2009: José A Gómez-Puerta; Ricard Cervera; Concepción Moll; Manel Solé; Antonio Collado; Raimon Sanmartí
Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy.
Clinical rheumatology 2009;28(1):95-7.
2008: José A Gómez-Puerta; Rufus W Burlingame; Ricard Cervera
Anti-chromatin (anti-nucleosome) antibodies: diagnostic and clinical value.
Autoimmunity reviews 2008;7(8):606-11.
2008: Concepción Moll; M Victoria Hernández; Juan D Cañete; José A Gómez-Puerta; Alex Soriano; Antonio Collado; Raimon Sanmartí
Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature.
Seminars in arthritis and rheumatism 2008;37(5):299-306.
2008: José A Gómez-Puerta; Pilar Peris; Manuel Llusá; Nuria Guañabens
Sacral stress fracture as a cause of gluteal artery injury: an unusual complication of a common fracture.
Joint, bone, spine : revue du rhumatisme 2008;75(2):239-41.
2007: Raimon Sanmartí; A Gómez-Centeno; Guadalupe Ercilla; Marta Larrosa; Octavi Viñas; I Vazquez; José A Gómez-Puerta; Jordi Gratacós; Georgina Salvador; Juan D Cañete
Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids.
Clinical rheumatology 2007;26(7):1111-8.
2007: Maria C Escobar; José A Gómez-Puerta; Dimpna Albert; Queralt Ferrer; Josep Girona
Recurrent congenital heart block in neonatal lupus.
Clinical rheumatology 2007;26(7):1161-3.
2007: Ricard Cervera; Silvia Bucciarelli; Gerard Espinosa; José A Gómez-Puerta; Manuel Ramos-Casals; Yehuda Shoenfeld; Jean-Charles Piette; Ronald A Asherson
Catastrophic antiphospholipid syndrome: lessons from the "CAPS Registry"--a tribute to the late Josep Font.
Annals of the New York Academy of Sciences 2007;1108():448-56.
2007: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Ronald A Asherson; Mario García-Carrasco; Izaias P da Costa; Danieli C O Andrade; Eduardo F Borba; Alexander Makatsaria; Silvia Bucciarelli; Manuel Ramos-Casals; Josep Font
Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases.
Annals of the rheumatic diseases 2007;66(6):740-6.
2007: José A Gómez-Puerta; Pilar Peris; Josep M Grau; M Angeles Martinez; Nuria Guañabens
Camptocormia as a clinical manifestation of mitochondrial myopathy.
Clinical rheumatology 2007;26(6):1017-9.
2007: Mario García-Carrasco; C Galarza; M Gómez-Ponce; Ricard Cervera; Jorge Rojas-Rodríguez; Gerard Espinosa; Silvia Bucciarelli; José A Gómez-Puerta; Albert Bové; Ricardo O Escárcega; Josep Font
Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients.
Lupus 2007;16(5):366-73.
2006: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; Josep Font
Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome.
Autoimmunity reviews 2006;6(2):85-8.
2006: Ricard Cervera; Gerard Espinosa; Silvia Bucciarelli; José A Gómez-Puerta; Josep Font
Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry.
Autoimmunity reviews 2006;6(2):81-4.
2006: Silvia Bucciarelli; Ricard Cervera; Gerard Espinosa; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.
Autoimmunity reviews 2006;6(2):72-5.
2006: Gerard Espinosa; Silvia Bucciarelli; Ricard Cervera; José A Gómez-Puerta; Josep Font
Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome.
Autoimmunity reviews 2006;6(2):68-71.
2006: Silvia Bucciarelli; Gerard Espinosa; Ricard Cervera; Doruk Erkan; José A Gómez-Puerta; Manuel Ramos-Casals; Josep Font; Ronald A Asherson
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.
Arthritis and rheumatism 2006;54(8):2568-76.
2006: José A Gómez-Puerta; Gerard Espinosa; José M Miró; Omar Sued; Josep M Llibre; Ricard Cervera; Josep Font
Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.
The Israel Medical Association journal : IMAJ 2006;8(7):513-4.
2006: José A Gómez-Puerta; Ricard Cervera; Gerard Espinosa; Sira Aguiló; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Ronald A Asherson; Josep Font
Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients.
Seminars in arthritis and rheumatism 2006;35(5):322-32.
2006: José A Gómez-Puerta; R W Burlingame; Ricard Cervera
Anti-chromatin (anti-nucleosome) antibodies.
Lupus 2006;15(7):408-11.
2006: Silvia Bucciarelli; Gerard Espinosa; Ronald A Asherson; Ricard Cervera; Gisela Claver; José A Gómez-Puerta; Manuel Ramos-Casals; Miguel Ingelmo
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients.
Annals of the rheumatic diseases 2006;65(1):81-6.
2005: José A Gómez-Puerta; Jorge Musuruana; Carlos Saez; Ricard Cervera; Josep Font
[Sarcoidosis as seronegative spondyloarthropathy].
Biomédica : revista del Instituto Nacional de Salud 2005;25(4):435-8.
2005: Ricard Cervera; Josep Font; José A Gómez-Puerta; Gerard Espinosa; M Cucho; Silvia Bucciarelli; Manuel Ramos-Casals; Miguel Ingelmo; Jean-Charles Piette; Yehuda Shoenfeld; Ronald A Asherson
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.
Annals of the rheumatic diseases 2005;64(8):1205-9.
2005: José A Gómez-Puerta; Helena Martín; Mary-Carmen Amigo; Maria A Aguirre; Maria T Camps; Maria J Cuadrado; G R V Hughes; Munther A Khamashta
Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
Medicine 2005;84(4):225-30.
2005: Ronald A Asherson; Gerard Espinosa; Ricard Cervera; José A Gómez-Puerta; J Musuruana; Silvia Bucciarelli; Manuel Ramos-Casals; A L Martínez-González; Miguel Ingelmo; Joan Carles Reverter; Josep Font; Douglas A Triplett
Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.
Annals of the rheumatic diseases 2005;64(6):943-6.
2005: José A Gómez-Puerta; Ricard Cervera; L M Calvo; Beatriz Gómez-Ansón; Gerard Espinosa; Gisela Claver; Silvia Bucciarelli; Albert Bové; Manuel Ramos-Casals; Miguel Ingelmo; Josep Font
Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.
Rheumatology (Oxford, England) 2005;44(1):95-9.
2004: MG Rivero; AJ Salvatore; José A Gómez-Puerta; José Mascaró; Juan D Cañete; José Muñoz-Gómez; Raimon Sanmartí
Accelerated nodulosis during methotrexate therapy in a patient with systemic lupus erythematosus and Jaccoud's arthropathy.
Rheumatology (Oxford, England) 2004;43(12):1587-8.
2004: Ricard Cervera; Ronald A Asherson; M L Acevedo; José A Gómez-Puerta; Gerard Espinosa; Gloria de la Red; Victor Gil; Manuel Ramos-Casals; Mario García-Carrasco; Miguel Ingelmo; Josep Font
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients.
Annals of the rheumatic diseases 2004;63(10):1312-7.
2004: José A Gómez-Puerta; Raimon Sanmartí; José Ramón Rodríguez-Cros; Juan D Cañete
Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
Annals of the rheumatic diseases 2004;63(7):896.
2004: Raimon Sanmartí; José A Gómez-Puerta; José Ramón Rodríguez-Cros; Carolina Albaladejo; José Muñoz-Gómez; Juan D Cañete
[Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab].
Medicina clínica 2004;122(9):321-4.
2004: José A Gómez-Puerta; Victor Gil; Ricard Cervera; R Miquel; S Jiménez; Manuel Ramos-Casals; Josep Font
Coeliac disease associated with systemic sclerosis.
Annals of the rheumatic diseases 2004;63(1):104-5.
2003: José A Gómez-Puerta; M Cucho Venegas; R Cervera Segura; J Font Franco
[Intravenous immunoglobulins in the systemic autoinmune diseases].
Revista clínica española 2003;203(11):548-54.
2003: José A Gómez-Puerta; Victor Gil; Ricard Cervera
"Catastrophic" antiphospholipid syndrome.
Mayo Clinic proceedings. Mayo Clinic 2003;78(4):519; author reply 519, 521.